Literature DB >> 23920037

The effects of lipoplex formulation variables on the protein corona and comparisons with in vitro transfection efficiency.

Jamie L Betker1, Joe Gomez, Thomas J Anchordoquy.   

Abstract

The use of lipoplexes for the intracellular delivery of nucleic acids typically involves the optimization of several parameters that are known to affect delivery. Researchers commonly vary charge ratio, and often incorporate different amounts of helper lipids (e.g., cholesterol) to optimize formulations for transfection in cell culture and in vivo. The results of such experiments are often interpreted in the context of nuclease resistance and cell association, but effects on the protein corona are usually not considered. While many studies have demonstrated that lipoplex structure and function can be dramatically compromised in the presence of serum, little attention has been paid to the adsorption of specific proteins and how this might be affected by formulation parameters. In this study, we characterize changes in the protein corona that occur as DOTAP-based lipoplexes are formulated with different amounts of cholesterol and prepared at different charge ratios. Our results demonstrate a significant effect of lipid composition on both total protein adsorption as well as the individual proteins from fetal calf serum that are associated with lipoplexes. In addition, we show that PEGylation increases protein adsorption with our formulations; effects that depend on the type of PEG conjugate employed in the lipoplex. Attempts to identify a specific protein responsible for enhancing transfection were unsuccessful.
© 2013.

Entities:  

Keywords:  Cholesterol; Lipoplex; MALDI/MS; Protein corona; Serum protein adsorption; Transfection

Mesh:

Substances:

Year:  2013        PMID: 23920037      PMCID: PMC3795791          DOI: 10.1016/j.jconrel.2013.07.024

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  49 in total

1.  Receptor versus non-receptor mediated clearance of liposomes.

Authors: 
Journal:  Adv Drug Deliv Rev       Date:  1998-06-08       Impact factor: 15.470

2.  The evolution of the protein corona around nanoparticles: a test study.

Authors:  Martin Lundqvist; Johannes Stigler; Tommy Cedervall; Tord Berggård; Michelle B Flanagan; Iseult Lynch; Giuliano Elia; Kenneth Dawson
Journal:  ACS Nano       Date:  2011-08-26       Impact factor: 15.881

3.  Inclusion of cholesterol in DOTAP transfection complexes increases the delivery of DNA to cells in vitro in the presence of serum.

Authors:  K Crook; B J Stevenson; M Dubouchet; D J Porteous
Journal:  Gene Ther       Date:  1998-01       Impact factor: 5.250

4.  Lipid mixing between lipoplexes and plasma lipoproteins is a major barrier for intravenous transfection mediated by cationic lipids.

Authors:  Bouna-Moussa Tandia; Caroline Lonez; Michel Vandenbranden; Jean-Marie Ruysschaert; Abdelatif Elouahabi
Journal:  J Biol Chem       Date:  2005-01-20       Impact factor: 5.157

5.  Influence of poly(ethylene glycol) grafting density and polymer length on liposomes: relating plasma circulation lifetimes to protein binding.

Authors:  Nancy Dos Santos; Christine Allen; Anne-Marie Doppen; Malathi Anantha; Kelly A K Cox; Ryan C Gallagher; Goran Karlsson; Katarina Edwards; Gail Kenner; Lacey Samuels; Murray S Webb; Marcel B Bally
Journal:  Biochim Biophys Acta       Date:  2007-01-03

6.  Pre-coating with serum albumin reduces receptor-mediated hepatic disposition of polystyrene nanosphere: implications for rational design of nanoparticles.

Authors:  Ken-ichi Ogawara; Kentaro Furumoto; Susumu Nagayama; Keiko Minato; Kazutaka Higaki; Toshiya Kai; Toshikiro Kimura
Journal:  J Control Release       Date:  2004-12-10       Impact factor: 9.776

7.  Effect of coupling of albumin onto surface of PEG liposome on its in vivo disposition.

Authors:  Kentaro Furumoto; Jun-Ichi Yokoe; Ken-ichi Ogawara; Sayuri Amano; Maki Takaguchi; Kazutaka Higaki; Toshiya Kai; Toshikiro Kimura
Journal:  Int J Pharm       Date:  2006-08-30       Impact factor: 5.875

8.  Cholesterol domains enhance transfection.

Authors:  Jamie L Betker; Max Kullberg; Joe Gomez; Thomas J Anchordoquy
Journal:  Ther Deliv       Date:  2013-04

9.  Cholesterol as a bilayer anchor for PEGylation and targeting ligand in folate-receptor-targeted liposomes.

Authors:  Xiaobin B Zhao; Natarajan Muthusamy; John C Byrd; Robert J Lee
Journal:  J Pharm Sci       Date:  2007-09       Impact factor: 3.534

10.  Surface adsorption of protein corona controls the cell internalization mechanism of DC-Chol-DOPE/DNA lipoplexes in serum.

Authors:  Giulio Caracciolo; Luciano Callipo; Sofia Candeloro De Sanctis; Chiara Cavaliere; Daniela Pozzi; Aldo Laganà
Journal:  Biochim Biophys Acta       Date:  2009-11-14
View more
  13 in total

Review 1.  Watching the gorilla and questioning delivery dogma.

Authors:  Thomas J Anchordoquy; Dmitri Simberg
Journal:  J Control Release       Date:  2017-07-14       Impact factor: 9.776

2.  Exploring the HYDRAtion method for loading siRNA on liposomes: the interplay between stability and biological activity in human undiluted ascites fluid.

Authors:  George R Dakwar; Kevin Braeckmans; Wim Ceelen; Stefaan C De Smedt; Katrien Remaut
Journal:  Drug Deliv Transl Res       Date:  2017-04       Impact factor: 4.617

Review 3.  Nanotechnology in cell replacement therapies for type 1 diabetes.

Authors:  Alexander U Ernst; Daniel T Bowers; Long-Hai Wang; Kaavian Shariati; Mitchell D Plesser; Natalie K Brown; Tigran Mehrabyan; Minglin Ma
Journal:  Adv Drug Deliv Rev       Date:  2019-02-02       Impact factor: 15.470

4.  Identification of peptide coatings that enhance diffusive transport of nanoparticles through the tumor microenvironment.

Authors:  Rashmi P Mohanty; Xinquan Liu; Jae Y Kim; Xiujuan Peng; Sahil Bhandari; Jasmim Leal; Dhivya Arasappan; Dennis C Wylie; Tony Dong; Debadyuti Ghosh
Journal:  Nanoscale       Date:  2019-10-03       Impact factor: 7.790

5.  The Use of Lactose as an Alternative Coating for Nanoparticles.

Authors:  Jamie L Betker; Thomas J Anchordoquy
Journal:  J Pharm Sci       Date:  2020-01-28       Impact factor: 3.534

6.  A novel method for conjugating the terminal amine of peptide ligands to cholesterol: synthesis iRGD-cholesterol.

Authors:  Matthew G Fete; Jamie L Betker; Richard K Shoemaker; Thomas J Anchordoquy
Journal:  Ther Deliv       Date:  2019-01

7.  Nonadditive Effects of Repetitive Administration of Lipoplexes in Immunocompetent Mice.

Authors:  Jamie L Betker; Thomas J Anchordoquy
Journal:  J Pharm Sci       Date:  2016-11-22       Impact factor: 3.534

8.  Nanoparticle uptake by circulating leukocytes: A major barrier to tumor delivery.

Authors:  Jamie L Betker; Dallas Jones; Christine R Childs; Karen M Helm; Kristina Terrell; Maria A Nagel; Thomas J Anchordoquy
Journal:  J Control Release       Date:  2018-07-17       Impact factor: 9.776

9.  Questioning the Use of PEGylation for Drug Delivery.

Authors:  Johan J F Verhoef; Thomas J Anchordoquy
Journal:  Drug Deliv Transl Res       Date:  2013-12       Impact factor: 4.617

Review 10.  Biocompatibility of nanomaterials and their immunological properties.

Authors:  Themis R Kyriakides; Arindam Raj; Tiffany H Tseng; Hugh Xiao; Ryan Nguyen; Farrah S Mohammed; Saiti Halder; Mengqing Xu; Michelle J Wu; Shuozhen Bao; Wendy C Sheu
Journal:  Biomed Mater       Date:  2021-03-11       Impact factor: 3.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.